Lexaria Bioscience (LEXX) EBT Margin Growth (1y) (2018 - 2026)
Lexaria Bioscience (LEXX) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
-566,963.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
-566,963.00 |
| Aug 31, 2025 |
107,082.00 |
| May 31, 2025 |
-8,040.00 |
| Feb 28, 2025 |
-112,035.00 |
| Nov 30, 2024 |
-71,477.00 |
| Aug 31, 2024 |
100,982.00 |
| May 31, 2024 |
101,473.00 |
| Feb 29, 2024 |
614,917.00 |
| Nov 30, 2023 |
98,654.00 |
| Aug 31, 2023 |
-310,365.00 |
| May 31, 2023 |
-66,444.00 |
| Feb 28, 2023 |
-188,336.00 |
| Nov 30, 2022 |
1.27 Mn |
| Aug 31, 2022 |
-49,990.00 |
| May 31, 2022 |
-116,743.00 |
| Feb 28, 2022 |
-415,125.00 |
| Nov 30, 2021 |
-1.43 Mn |
| Aug 31, 2021 |
132,765.00 |
| May 31, 2021 |
261,413.00 |
| Feb 28, 2021 |
225,219.00 |
